CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to BTMD

IMA402 (Phase Ia)

Phase 2
biote Corp. (BTMD)

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Sep '27
BTMDPhase 2

IMA402 (Phase Ia) Phase 2 Est. Readout

IMA402 (Phase Ia)
Sep 2027~
CT.gov
00%
Competitive Landscape

0 competitors in Refractory Cancer

View Full Landscape
Drug Information

Target Indication

Refractory Cancer

Clinical Trial

NCT05958121

Last updated: 6/26/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.